m
Registry
C09DA04 #57728

Gizlan -Plus 150mg/12.5mg

Irbesartan 150 mg, Hydrochlorothiazide 12.5 mg
Consumer price
JOD 5.99
▼ 8.0%from JOD 6.51
#26 of 31 by price
Product details
Concentration
150 mg, 12.5 mg
Packaging
30
Manufacturer
Dar Al Dawa Development and Investment Co Ltd/Jordan
الاردن
Brand owner
Dar Al Dawa Development and Investment Co Ltd/Jordan
الاردن
Distributor
Dar Al Dawa Development and Investment Co Ltd
شركة دار الدواء للتنمية والأستثمار
Registered
Pricing · JOD
Consumer
JOD 5.99
Previous
JOD 6.51
Pharmacist
JOD 4.75
Hospital
Sales tax
JOD 0.24
With tax
JOD 6.23
Price history
2 distinct prices since tracking began
JOD 5.99 – 6.51
range
6.51 · before tracking5.99 · May 25 · 22:23
Competitive landscape

Every brand of Irbesartan

Full molecule →
BrandStrengthManufacturerPrice
Co-Irda 150mg/12.5 mg
150 mg, 12.5 mg NOBEL ILAC SANAYII VE TICARET A.S TR JOD 2.62 View
Irda 150mg F.C Tablets
150 mg NOBEL ILAC SANAYII VE TICARET A.S TR JOD 2.62 View
Co-Irda 300mg/12.5 mg
300 mg, 12.5 mg NOBEL ILAC SANAYII VE TICARET A.S TR JOD 3.11 View
Co-Irda 300mg/25mg F.C.T
300 mg, 25 mg NOBEL ILAC SANAYII VE TICARET A.S TR JOD 3.11 View
Irda 300mg F.C Tab
300 mg NOBEL ILAC SANAYII VE TICARET A.S TR JOD 3.11 View
Procard 150mg
150 mg JUBILANT GENERICS LIMITED/INDIA IN JOD 4.00 View
Procard 300mg
300 mg JUBILANT GENERICS LIMITED/INDIA IN JOD 4.00 View
Converium 150mg
150 mg MEDOCHEMIE LTD/CENTRAL FACTORY/CYPRUS CY JOD 4.36 View
Converium 300mg
300 mg MEDOCHEMIE LTD/CENTRAL FACTORY/CYPRUS CY JOD 4.36 View
Procard Plus 150/12.5
150 mg, 12.5 mg Al-Taqqadom Pharmaceutical Industries JO JOD 4.38 View
Irbegen 150mg
150 mg Genepharm S.A GR JOD 4.40 View
Irbegen 300mg
300 mg Genepharm S.A GR JOD 4.40 View
Irbegen Plus 150/12.5 mg
150 mg, 12.5 mg Genepharm S.A GR JOD 4.72 View
Irbegen Plus 300/12.5mg
300 mg, 12.5 mg Genepharm S.A GR JOD 4.72 View
Irbegen Plus 300/25mg
300 mg, 25 mg Genepharm S.A GR JOD 4.72 View
Signals on this product
registered
New registration: Gizlan -Plus 150mg/12.5mg (Irbesartan 150 mg, Hydrochlorothiazide 12.5 mg)
May 25 · 22:23
Raw JFDA record
{
  "ATCCODE": "C09DA04",
  "CLASSIFICATION_CODE": 0,
  "CLASSIFICATION_NAME": null,
  "COMPANY_DESC_A": "Dar Al Dawa Development and Investment Co Ltd/Jordan",
  "CONC_UNIT": null,
  "COUNTRY_DESC_A": "\u0627\u0644\u0627\u0631\u062f\u0646",
  "DOSAGEFORM": null,
  "DRG_BARCODE": "6251107378217",
  "DRG_BARCODE_SER": "57728",
  "DRG_B_R_CMP_CODE": null,
  "DRG_B_R_CMP_COUNTRY_CODE": 0,
  "DRG_CAN_TYPE": 0,
  "DRG_CLASS_TYPE": 0,
  "DRG_CODE": 57728,
  "DRG_CONCENTRATE": "150 mg, 12.5 mg",
  "DRG_CURRENCY_TRANSFORM_FAC": 0,
  "DRG_CURRENT_HOSP_PRICE": 0,
  "DRG_CURRENT_JORD_CITIZEN_PRICE": 5.99,
  "DRG_CURRENT_JORD_PHARM_PRICE": 4.75,
  "DRG_DESC_A": null,
  "DRG_DESC_L": "Gizlan -Plus 150mg/12.5mg",
  "DRG_DEST_STORE_PRICE": 0,
  "DRG_EXPORT_CURRENCY_CODE": 0,
  "DRG_EXPORT_PRICE": null,
  "DRG_FILLING": "30",
  "DRG_INDUST_CMP": null,
  "DRG_INDUST_CMP_CODE": 23514,
  "DRG_INDUST_CMP_COUNTRY": null,
  "DRG_INDUST_CMP_COUNTRY_CODE": 35,
  "DRG_JORD_PRICE_ORG_CONT": 0,
  "DRG_JORD_PRICE_ORG_FAC": 0,
  "DRG_JORD_PRICE_ORG_HOSP": 0,
  "DRG_LEAGUE_DATE": "/Date(-62135596800000)/",
  "DRG_LOCAL_FLAG": 1,
  "DRG_MEDICAL_CLASSIFICATION": null,
  "DRG_NATURE": 2,
  "DRG_ORIGIN_CAN_SIZE": 0,
  "DRG_ORIGIN_CITIZEN_CURRENCY": null,
  "DRG_ORIGIN_CITIZEN_PRICE": null,
  "DRG_ORIGIN_CONT_CODE": 0,
  "DRG_ORIGIN_CONT_HOSP": 0,
  "DRG_ORIGIN_CONT_HOSP_CUR": 0,
  "DRG_ORIGIN_FACTORY_CURRENCY": 0,
  "DRG_ORIGIN_FACTORY_PRICE": null,
  "DRG_ORIGIN_NET_COUNTRY": 0,
  "DRG_ORIGIN_NET_CURRNCY": 0,
  "DRG_ORIGIN_NET_PRICE": 0,
  "DRG_ORIG_FAC_CONT_CODE": 0,
  "DRG_ORIG_HOS_CONT_CODE": 0,
  "DRG_PRICE_ACTIVEDATE": null,
  "DRG_PRICE_PREVPRICE": 0,
  "DRG_PRICE_PREVPRICE_WTAX": null,
  "DRG_PRIMARY_CMP_CODE": 0,
  "DRG_PRIMARY_CMP_COUNTRY_CODE": 0,
  "DRG_PRV_HOSP_PRICE": 0,
  "DRG_PRV_JORD_CITIZEN_PRICE": 6.51,
  "DRG_PRV_JORD_PHARM_PRICE": 5.17,
  "DRG_REGION_CODE": 0,
  "DRG_REGION_FAC": -1,
  "DRG_REG_NO": null,
  "DRG_REG_NO1": null,
  "DRG_REG_NO2": 0,
  "DRG_REMARK": null,
  "DRG_RENUAL_NO": null,
  "DRG_RENUAL_NO1": null,
  "DRG_RENUAL_NO2": 0,
  "DRG_RENUAL_NO3": 0,
  "DRG_RENUAL_NO4": 0,
  "DRG_SALES_CMP_CODE": 0,
  "DRG_SALES_CMP_NAME": null,
  "DRG_SALES_COUNTRY_CODE": "35",
  "DRG_SALES_TAX": 0.24,
  "DRG_SAUDI_COMPARISON_FALG": 0,
  "DRG_SCIENTIFIC_STRUCTURE": null,
  "DRG_SECONDARY_CMP_CODE": 0,
  "DRG_SECONDARY_CMP_COUNTRY_CODE": 0,
  "DRG_SHIP_CMP_CODE": 0,
  "DRG_SHIP_TYPE": null,
  "DRG_STORE_CODE": 63,
  "DRG_TAXED_HOSP_PRICE": 0,
  "DRG_TAXED_JORD_CITIZEN_PRICE": 6.23,
  "DRG_TYPE": 1,
  "DRG_TYPE_DESC": null,
  "DRG_USERID_DEL_CODE": null,
  "DRG_USERID_DEL_DATE": "/Date(-62135596800000)/",
  "DRG_USERID_INS_CODE": null,
  "DRG_USERID_INS_DATE": "/Date(-62135596800000)/",
  "DRG_USERID_UPD_CODE": null,
  "DRG_USERID_UPD_DATE": "/Date(-62135596800000)/",
  "DRUG_DISCOUNT_FLAG": 0,
  "DRUG_GROUP_ID": 0,
  "DRUG_ROUTE": null,
  "ERRORDESC": null,
  "EXPIRY": null,
  "GENERICNAME": null,
  "INGREDIENT": null,
  "INGREDIENTS": "Irbesartan 150 mg, Hydrochlorothiazide 12.5 mg",
  "INGRLKP_NAME": null,
  "INGR_SOURCE": null,
  "INSERTED_DATE": "/Date(-62135596800000)/",
  "INVOICER": "DAD",
  "ISSUE_CODE": 0,
  "JHP": 0,
  "JPP": 0,
  "LEAFLET_RD": null,
  "LIST_CLASSIFICATION": null,
  "LIST_CODE": 0,
  "LIST_NAME": null,
  "MAH_E": "Dar Al Dawa Development and Investment Co Ltd/Jordan",
  "MARKETED_FLAG": 0,
  "MODELSTA": false,
  "Marketing_Country": "\u0627\u0644\u0627\u0631\u062f\u0646",
  "RATIONAL_FLAG": 0,
  "RECORD_CURRENT_STATUS": 0,
  "RECORD_CURRENT_STATUS_DESC": null,
  "RECORD_STATUS": 0,
  "RECORD_STATUS_DESC": null,
  "RECORD_TYPE_CODE": 0,
  "RECORD_TYPE_DESC": null,
  "REGISTRATION_DATE": "/Date(-62135596800000)/",
  "REGISTRATION_DECISION_DATE": "/Date(-62135596800000)/",
  "REGISTRATION_REQUEST_DATE": "/Date(-62135596800000)/",
  "REGISTRATION_REQUEST_NUMBER": null,
  "REG_REQ_DATE": null,
  "RE_REGISTRATION_DATE": "/Date(-62135596800000)/",
  "SHIP_TYPE_DESC": null,
  "SREGISTRATION_DATE": null,
  "SRE_REGISTRATION_DATE": null,
  "STORES_DESC_A": "\u0634\u0631\u0643\u0629 \u062f\u0627\u0631 \u0627\u0644\u062f\u0648\u0627\u0621 \u0644\u0644\u062a\u0646\u0645\u064a\u0629 \u0648\u0627\u0644\u0623\u0633\u062a\u062b\u0645\u0627\u0631",
  "STORES_DESC_L": "Dar Al Dawa Development and Investment Co Ltd",
  "STORING_CONDITIONS": null,
  "TypeGroup": null,
  "UPDATED_DATE": "/Date(-62135596800000)/",
  "ingname": null,
  "lDrugCompany": null,
  "leaflet_file_name": null,
  "lstDrug": null,
  "lstDrugLog": null,
  "lstIngredients": null,
  "lstStore": null,
  "message": null,
  "nature": null,
  "title": null
}